Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRISÂ® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting<4502.T>